1034827-56-9 Usage
General Description
4-Bromo-2-(trifluoromethyl)pyrimidine is a chemical compound with the molecular formula C6H3BrF3N2. It is an organic compound that contains a pyrimidine ring with a bromo substituent at the 4-position and a trifluoromethyl group at the 2-position. 4-broMo-2-(trifluoroMethyl)pyriMidine is commonly used in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals. It is a white to off-white solid that is sparingly soluble in water but soluble in organic solvents. 4-Bromo-2-(trifluoromethyl)pyrimidine is also a valuable building block for creating a variety of functional molecules in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 1034827-56-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,4,8,2 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1034827-56:
(9*1)+(8*0)+(7*3)+(6*4)+(5*8)+(4*2)+(3*7)+(2*5)+(1*6)=139
139 % 10 = 9
So 1034827-56-9 is a valid CAS Registry Number.
1034827-56-9Relevant articles and documents
ANTIDIABETIC SPIROCHROMAN COMPOUNDS
-
Page/Page column 121, (2018/07/29)
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.
BIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
-
Page/Page column 38-39, (2008/12/07)
Bipiperidinyl compounds of the formula I, are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.
